Improving adherence with treatment-resistant hypertension

Effect of Mobile Educational Application on Adherence to Treatment in Elderly with Hypertension

Background and purpose: Adherence to treatment has a key role in management of hypertension and mobile phones can be used to educate patients. The aim of this study was to investigate the effect of a mobile educational application on adherence to treatment in elderly with hypertension. Materials and methods: This randomized clinical trial was conducted in Neishabour, Iran 2020. A total of 54 r...

Improving adherence to drugs for hypertension.

http://bmj.com/cgi/content/full/335/7628/1002 Updated information and services can be found at: These include: References http://bmj.com/cgi/content/full/335/7628/1002#BIBL This article cites 4 articles, 2 of which can be accessed free at: Rapid responses http://bmj.com/cgi/eletter-submit/335/7628/1002 You can respond to this article at: http://bmj.com/cgi/content/full/335/7628/1002#responses f...

Improving Medication Adherence in Patients with Hypertension: A Randomized Trial.

BACKGROUND AND PURPOSE In patients with hypertension, medication adherence is often suboptimal, thereby increasing the risk of ischemic heart disease and stroke. In a randomized trial, we investigated the effectiveness of a multifaceted pharmacist intervention in a hospital setting to improve medication adherence in hypertensive patients. Motivational interviewing was a key element of the inter...

The association between medication adherence and treatment intensification with blood pressure control in resistant hypertension.

Patients with resistant hypertension are at risk for poor outcomes. Medication adherence and intensification improve blood pressure (BP) control; however, little is known about these processes or their association with outcomes in resistant hypertension. This retrospective study included patients from 2002 to 2006 with incident hypertension from 2 health systems who developed resistant hyperten...

Psychological Therapies: The Missing Link in Improving Treatment Adherence in Patients with β-thalassemia Major